BIOAVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE-ACETATE AFTER ORAL-ADMINISTRATION OF 2.0-MG CYPROTERONE-ACETATE IN COMBINATION WITH 50 MUG ETHINYLESTRADIOL TO 6 YOUNG-WOMEN

被引：22

作者：

HUMPEL, M ^{[1
]}

WENDT, H ^{[1
]}

SCHULZE, PE ^{[1
]}

DOGS, G ^{[1
]}

WEISS, C ^{[1
]}

SPECK, U ^{[1
]}

机构：

[1] SCHERING AG,RES LABS,BERLIN,FED REP GER

来源：

关键词：

D O I：

10.1016/0010-7824(77)90108-1

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：579 / 588

页数：10

共 8 条

[1] BHARGAVA AP, IN PRESS
[2] GERHARDS E, 1973, ARZNEIMITTEL-FORSCH, V23, P1550
[3] HUMPEL M, IN PRESS
[4] Kolb K H, 1968, Int Z Klin Pharmakol Ther Toxikol, V1, P184
[5] NIEUWEBOER B, IN PRESS
[6] PHARMACOKINETICS OF BETA-ADRENERGIC BLOCKER SOTALOL IN DOGS
SCHNELLE, K
GARRETT, ER
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (03) : 362 - 375
[7] BIO-AVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE ACETATE-C-14 AND ETHINYLOESTRADIOL-H-3 AFTER ORAL-ADMINISTRATION AS A COATED TABLET (SH B 209 AB)
SPECK, U
WENDT, H
SCHULZE, PE
JENTSCH, D
[J]. CONTRACEPTION, 1976, 14 (02) : 151 - 163
[8] SPECK U, 1976, ARZNEIMITTEL-FORSCH, V26, P1717